In a comprehensive analysis published in The Lancet Psychiatry, researchers have found that the antidepressant escitalopram outperformed Prozac (fluoxetine) and two other drugs - agomelatine and duloxetine - in preventing relapse among depression patients. The study involved nearly 10,000 individuals who were prescribed different medications for up to a year. Despite these findings, experts stress that the choice of medication should be individualized, taking into account each patient's unique circumstances and response to treatment.

The analysis compared the effectiveness of more than a dozen common antidepressants, with modest differences found between them. Depression is a prevalent issue, affecting approximately one in six people in the UK. While longer studies are needed to further understand these differences, the right treatment and support can lead to recovery for many individuals. To prevent relapse, doctors often recommend patients stay on antidepressants for at least six months after depression subsides, before gradually tapering off.

Experts emphasize that while escitalopram may have a slight advantage over other antidepressants for longer-term outcomes, the differences are relatively small and may not outweigh individual factors such as side effects, previous response, and patient preference when deciding on treatment. It is essential to discuss treatment options with a healthcare provider. The study's findings do not suggest that everyone with severe depression should switch to escitalopram or that other antidepressants are ineffective.

Like all medications, escitalopram can cause side effects such as sleep problems, constipation, and weight gain. If escitalopram or a similar SSRI is ineffective or not suitable, doctors may recommend a different type of antidepressant, such as an SNRI. Older tricyclic antidepressants, like amitriptyline, are less commonly prescribed nowadays. Patients should have access to clear information about the potential benefits and side effects of antidepressants, as well as other forms of support, including talking therapies and mindfulness practices. The mental health charity Mind provides resources for comparing different antidepressants on their website.